Story thread · 6 reports / 5 sources

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine

financialpost.com · 14d

How the coverage leans

Across 5 sources · syndicated copies counted once

Wall Street sees new treatments as an untapped goldmine, full of consumers who are willing to pay out-of-pocket for better options

First report: Hair-Loss Drug Stocks Soar as Wall Street’s Next Big Bet After GLP-1 Boom bloomberg.com, 16d

The coverage

  1. Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade

    beincrypto.com · 15d

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.